WO1994010974A1 - Cosmetic preparations for revitalising the skin - Google Patents

Cosmetic preparations for revitalising the skin Download PDF

Info

Publication number
WO1994010974A1
WO1994010974A1 PCT/FR1993/001077 FR9301077W WO9410974A1 WO 1994010974 A1 WO1994010974 A1 WO 1994010974A1 FR 9301077 W FR9301077 W FR 9301077W WO 9410974 A1 WO9410974 A1 WO 9410974A1
Authority
WO
WIPO (PCT)
Prior art keywords
approximately
vitamin
external use
preparations according
creams
Prior art date
Application number
PCT/FR1993/001077
Other languages
French (fr)
Inventor
Lucien Eustatiu
Original Assignee
Lucien Eustatiu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lucien Eustatiu filed Critical Lucien Eustatiu
Priority to US08/211,807 priority Critical patent/US5520991A/en
Priority to EP93924663A priority patent/EP0620726A1/en
Publication of WO1994010974A1 publication Critical patent/WO1994010974A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11Encapsulated compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/673Vitamin B group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/987Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
    • A61K8/988Honey; Royal jelly, Propolis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Definitions

  • the present invention relates to the field of cosmetics.
  • the present invention relates to various cosmetic preparations which revitalize the skin, each preparation being enriched with vitamins.
  • the various preparations are applied externally, by simple spreading on the skin and orally.
  • the document FR-A-2,585,568 relates to new cosmetic compositions, comprising a lipid derived from horny cells which can improve the ability of the stratum corneum to retain moisture. They are useful for the treatment of dry skin. When the lipid is used in combination with surfactants, the above effect is improved.
  • the cosmetic compositions can be presented according to any type of preparation, such as creams, milky lotions, beauty masks, lipsticks, foundations, hair tonics and the like.
  • This document reveals the different types of preparation that can allow the treatment of dry skin.
  • Document FR-A-2,631,824 relates to cosmetic compositions which contain, in combination, a component formed by an aromatic mixture of essential oils extracted from plants chosen from: Lavender, Geranium, Rosemary, Eucalyptus, Sage, Thyme, Cupréssus, Basil, Pereira Myroxylon, Lahafil kernels and a component containing vitamins A and E, gin ⁇ eng and 1 inal eol gamal acid.
  • This document reveals the use of vitamins A and E and the use of plant extracts.
  • the present invention relates to cosmetic preparations revitalizing the skin of the type using products for use external to the human body and a product for internal use in said human body, characterized in that the products for external use are formed of two creams and d '' a solution, which stimulates epidermal cells and fibroblasts of the dermis and which protect the epidermis and that the product for internal use consists of capsules which transport, to epidermal cells and fibroblasts, inter alia, amino acids and trace elements.
  • a subject of the invention is also cosmetic preparations, characterized in that the total mass of the product for internal use comprises from 33.4 to 34.4 per 100, hereinafter represented by the symbol of the percentage%, of amino acids , from 23.7 to 24.7% of lecithin, from 22.1 to 23.1% of lyophilized royal jelly, from 4.8 to 5.4% of vitamin C, substantially 0.1% of vitamin B6, substantially 0.02% of vitamin B12, and approximately 0.02% of trace elements.
  • the subject of the invention is also cosmetic preparations characterized in that the amino acids are in equivalent proportions lysine, serine, histidine, threonine, valine and / or leucine.
  • Another object of the present invention is to provide cosmetic preparations characterized by the fact that the trace elements are formed by selenium, zinc, magnesium, iron, manganese, copper, potassium, cobalt, phosphorus, silicon, chromium and / or vanadium.
  • Another object of the present invention is to provide cosmetic preparations characterized by the fact that the mass of each cream for external use comprises substantially 1% of oil essential oil of Roman chamomile, approximately 1.5% royal jelly, approximately 2% wheat germ oil, approximately 0.25% vitamin A, approximately 0.25% vitamin E, approximately 0.25% vitamin F, approximately 0.5% of biostimulins, and approximately 0.5% of allantoin.
  • Another object of the invention is to provide cosmetic preparations characterized by the fact that one of the two creams for external use comprises a moisturizing factor of plant origin representing substantially 2.5% of the mass of said cream for external use .
  • Another object of the invention is to provide cosmetic preparations characterized by the fact that the mass of the solution for external use comprises from 9.5 to 10.5% of Aloes Vera extracts enriched in biostimulins, substantially 0, 25% of vitamin A, approximately 0.25% of vitamin E, and approximately 0.25% of vitamin F.
  • An object of the invention is to provide cosmetic preparations characterized by the fact that the solution for external use uses as excipient plant extracts enriched with natural moisturizing factor.
  • the subject of the present invention is the use of cosmetic preparations characterized by the fact that
  • the present invention has the advantage of considering the skin as it is, that is to say as a complex organ of our organism. Thus, it must provide stimulation from the outside but above all provide it from the inside, all the substances necessary for the biosynthesis of elastin and collagen, which will allow the skin to respond favorably to external stimulation.
  • Said external stimulation is the result of external factors such as biostimulins which have a role of general stimulation on all the epidermal cells as well as on the fibroblasts of the dermis which synthesize the elastic matrix formed of collagen and elastin.
  • This fibroblast biosynthesis depends on the supply of specific amino acids which are lacking in the organism.
  • cosmetic preparations regenerating the skin are of the type using products for use external to the human body but also a product for internal use in said human body.
  • the products for external use stimulate all the epidermal cells as well as the fibroblasts present in the dermis and, moreover, allow the revitalization and the hydration of the epidermis.
  • the product for internal use for its part, carries several elements including amino acids and trace elements.
  • the product for internal use consists of amino acids, lecithin, freeze-dried royal jelly, vitamins and trace elements.
  • the products for external use consist of two creams and a solution.
  • Creams for external use are made of essential oils, Roman chamomile, freeze-dried royal jelly and wheat germ oil, vitamins, biostimulins and allantoin, while the solution for external use is formed of vitamins , extracts of Aloe Vera, and biostimulins.
  • the solution for external use uses as excipient plant extracts enriched with natural moisturizing factor such as tea extracts.
  • the mass thereof comprises 33.9% of amino acids.
  • amino acids are, in equivalent proportion to one another, lysine, serine, histidine, threonine, valine and / or leucine.
  • the mass of the product for internal use also includes 24.2% lecithin, 22.6% lyophilized royal jelly, 19.7% vitamins including vitamins C, B6 and B12 which are found in the following respective proportions: 5.1%, 0.1% and 0.02%.
  • Trace elements are numerous and essential in the biosynthesis of elastin and collagen. They include selenium, zinc, magnesium, iron, manganese, copper, potassium, cobalt, germanium, phosphate, silicon, chromium and / or vanadium.
  • Said trace elements are found in substantially equivalent proportion to each other and form 0.02% of the mass of the product for internal use.
  • the two creams for external use have a composition identical to one element.
  • the mass of each cream for external use includes 1
  • One of the two daytime creams additionally includes a moisturizing factor of plant origin which is found in a proportion of 2.5% in the mass of the cream for external use containing it.
  • the other cream is for night use.
  • Creams for external use whether day or night use, use as an excipient an emulsion of the oil-in-water type which allows to have creams for external use which have the property of having a hydrogen potential. (Ph) equal to 6.8.
  • the last product of these cosmetic preparations is the solution for external use. Its mass includes 10% Aloe Vera extracts, 0.5% biostimulins, but also 0.75% vitamins distributed as follows: 0.25% Vitamins A, 0.25% of vitamin E and 0.25% of vitamin F.
  • This solution for external use has for excipient vegetable extracts enriched in natural hydrating factor, such as extracts of tea.
  • the aim of the studies was to assess the properties of the complete treatment using the two creams, one for the day, the other for the night, and the solution as well as the product for internal use, the latter being presented in the form capsules.
  • the administration of the capsules was daily, three times a day, that is to say in the morning, noon and evening.
  • the application of the regenerating day cream was daily, at eight in the morning.
  • the application of the regenerating and firming cream at night was daily, days around 10 pm.
  • the application of the solution was also daily, around eight o'clock in the morning.
  • results are expressed in% corresponding to the surface of the skin forming the trays or the furrows compared to the 100 % of skin area studied by reference.
  • This method therefore consists in treating the skin from the outside and from the inside at the same time with active substances. which are found at the tissue level of the skin, while participating together in the process of revitalizing said skin with proven effects on the thickening of the epidermis, on its hydration, on the enlargement of the plateaus and on the reduction of furrows.

Abstract

The present invention relates to various cosmetic preparations which revitalize the skin, each preparation beeing enriched with vitamins. The invention discloses cosmetic preparations for skin revitalization which are comprised of products for use externally to the human body and a product for use internally to said human body, the cosmetic preparations being characterized in that the external use products are comprised of two creams and one solution which stimulate the epidermal cells and the fibroblast of the dermis, while protecting the epidermis, and in that the internal use product is comprised of capsules which carry aminoacids and oligoelements to the fibroblasts of the dermis. The present invention relates to the field of cosmetics.

Description

"Préparations cosmétiques revitalisant la peau" "Cosmetic preparations revitalizing the skin"
La présente invention se rapporte au domaine des cosmétiques. La présente invention concerne différentes préparations cosmétiques qui revitalisent la peau, chaque préparation étant enrichie en vitamines.The present invention relates to the field of cosmetics. The present invention relates to various cosmetic preparations which revitalize the skin, each preparation being enriched with vitamins.
Les différentes préparations s'appliquent par voie externe, par simple étalement sur la peau et par voie orale.The various preparations are applied externally, by simple spreading on the skin and orally.
Ces deux modes d'application agissent en synergie. De nombreux documents traitent de ces problèmes epidermiques et dermiques.These two modes of application act in synergy. Many documents deal with these epidermal and dermal problems.
Ainsi le document FR-A-2.585.568 concerne de nouvelles compositions cosmétiques , comprenant un lipide dérivé des cellules cornées qui peut améliorer l 'aptitude que présente la couche cornée à retenir 1 'humidité. Elles sont utiles pour le traitement des peaux sèches . Lorsque le lipide est utilisé en combinaison avec des agents tensio-actifs , 1 'effet ci-dessus est amélioré. Les compositions cosmétiques peuvent se présenter suivant n 'importe quel type de préparation, comme des crèmes, lotions laiteuses, masques de beauté, rouges à lèvres, fonds de teint, toniques capillaires et similaires.Thus the document FR-A-2,585,568 relates to new cosmetic compositions, comprising a lipid derived from horny cells which can improve the ability of the stratum corneum to retain moisture. They are useful for the treatment of dry skin. When the lipid is used in combination with surfactants, the above effect is improved. The cosmetic compositions can be presented according to any type of preparation, such as creams, milky lotions, beauty masks, lipsticks, foundations, hair tonics and the like.
Ce document révèle les différents types de préparation qui peuvent permettre le traitement des peaux sèches.This document reveals the different types of preparation that can allow the treatment of dry skin.
Le document FR-A-2.631.824 concerne des compositions cosmétiques qui renferment, en association, un composant formé d 'un mélange aromatique d 'huiles essentielles extraites de plantes choisies parmi : Lavande, Géranium, Romarin, Eucalyptus , Sauge, Thym, Cupréssus , Basilic, Myroxylon péréiraé, Lahafil noyaux et un composant renfermant les vitamines A et E, du ginεeng et de 1 ' acide gamal inol éique . Ce document révèle 1 'utilisation des vitamines A et E et l'utilisation d'extraits de plantes.Document FR-A-2,631,824 relates to cosmetic compositions which contain, in combination, a component formed by an aromatic mixture of essential oils extracted from plants chosen from: Lavender, Geranium, Rosemary, Eucalyptus, Sage, Thyme, Cupréssus, Basil, Pereira Myroxylon, Lahafil kernels and a component containing vitamins A and E, ginεeng and 1 inal eol gamal acid. This document reveals the use of vitamins A and E and the use of plant extracts.
Tous ces documents n'abordent le problème de revitalisation de la peau que par une simple application externe, sensée stimuler la rétention 'eau par les cellules. La présente invention a pour objet des préparations cosmétiques revitalisant la peau du type utilisant des produits à usage externe au corps humain et un produit à usage interne audit corps humain, caractérisées par le fait que les produits à usage externe sont formés de deux crèmes et d'une solution, qui stimulent les cellules epidermiques et les fibroblastes du derme et qui protègent 1'épiderme et que le produit à usage interne est formé de gélules qui véhiculent, jusqu'aux cellules epidermiques et aux fibroblastes, entre autres, des acides aminés et des oligo¬ éléments. L'invention a également pour objet des préparations cosmétiques caractérisées par le fait que la masse totale du produit à usage interne comprend de 33,4 à 34,4 pour 100, ci-après représenté par le symbole du pourcentage %, d'acides aminés, de 23,7 à 24,7 % de lécithine, de 22,1 à 23,1 % de gelée royale lyophilisée, de 4,8 à 5,4 % de vitamine C, sensiblement 0,1 % de vitamine B6, sensiblement 0,02 % de vitamine B12, et sensiblement 0,02 % d'oligo-éléments.All of these documents only tackle the problem of revitalizing the skin with a simple external application, which is supposed to stimulate the retention of water by the cells. The present invention relates to cosmetic preparations revitalizing the skin of the type using products for use external to the human body and a product for internal use in said human body, characterized in that the products for external use are formed of two creams and d '' a solution, which stimulates epidermal cells and fibroblasts of the dermis and which protect the epidermis and that the product for internal use consists of capsules which transport, to epidermal cells and fibroblasts, inter alia, amino acids and trace elements. A subject of the invention is also cosmetic preparations, characterized in that the total mass of the product for internal use comprises from 33.4 to 34.4 per 100, hereinafter represented by the symbol of the percentage%, of amino acids , from 23.7 to 24.7% of lecithin, from 22.1 to 23.1% of lyophilized royal jelly, from 4.8 to 5.4% of vitamin C, substantially 0.1% of vitamin B6, substantially 0.02% of vitamin B12, and approximately 0.02% of trace elements.
L'invention a encore pour objet des préparations cosmétiques caractérisées par le fait que les acides aminés sont en proportions équivalentes la lysine, la serine, l'histidine, la thréonine, la valine et/ou la leucine.The subject of the invention is also cosmetic preparations characterized in that the amino acids are in equivalent proportions lysine, serine, histidine, threonine, valine and / or leucine.
Un autre objet de la présente invention est de proposer des préparations cosmétiques caractérisées par le fait que les oligo¬ éléments sont formés par du sélénium, du zinc, du magnésium, du fer, du manganèse, du cuivre, du potassium, du cobalt, du phosphore, du silicium, du chrome et/ou du vanadium.Another object of the present invention is to provide cosmetic preparations characterized by the fact that the trace elements are formed by selenium, zinc, magnesium, iron, manganese, copper, potassium, cobalt, phosphorus, silicon, chromium and / or vanadium.
Un autre objet de la présente invention est de proposer des préparations cosmétiques caractérisées par le fait que la masse de chaque crème à usage externe comprend sensiblement 1 % d'huile essentielle de camomille romaine, sensiblement 1,5 % de gelée royale, sensiblement 2 % d'huile de germe de blé, sensiblement 0,25 % de vitamine A, sensiblement 0,25 % de vitamine E, sensiblement 0,25 % de vitamine F, sensiblement 0,5 % de biostimulines, et sensiblement 0,5 % d'allantoïne.Another object of the present invention is to provide cosmetic preparations characterized by the fact that the mass of each cream for external use comprises substantially 1% of oil essential oil of Roman chamomile, approximately 1.5% royal jelly, approximately 2% wheat germ oil, approximately 0.25% vitamin A, approximately 0.25% vitamin E, approximately 0.25% vitamin F, approximately 0.5% of biostimulins, and approximately 0.5% of allantoin.
Un autre objet de l'invention est de proposer des préparations cosmétiques caractérisées par le fait que l'une des deux crèmes à usage externe comprend un facteur hydratant d'origine végétale représentant sensiblement 2,5% de la masse de ladite crème à usage externe.Another object of the invention is to provide cosmetic preparations characterized by the fact that one of the two creams for external use comprises a moisturizing factor of plant origin representing substantially 2.5% of the mass of said cream for external use .
Un autre objet de la présente invention est de proposer des préparations cosmétiques caractérisées par le fait que les crèmes à usage externe utilisent pour excipient une é ulsion du type huile-dans-eau. Un autre objet de l'invention est de proposer des préparations cosmétiques caractérisées par le fait que les crèmes à usage externe ont un potentiel hydrogène sensiblement égal à 6,8.Another object of the present invention is to provide cosmetic preparations characterized by the fact that creams for external use use as an excipient an oil-in-water type emulsion. Another object of the invention is to provide cosmetic preparations characterized by the fact that creams for external use have a hydrogen potential substantially equal to 6.8.
Un autre objet de l'invention est de proposer des préparations cosmétiques caractérisées par le fait que la masse de la solution à usage externe comprend de 9,5 à 10,5 % d'extraits d'Aloes Vera enrichis en biostimulines, sensiblement 0,25 % de vitamine A, sensiblement 0,25 % de vitamine E, et sensiblement 0,25 % de vitamine F. Un objet de l'invention est de proposer des préparations cosmétiques caractérisées par le fait que la solution à usage externe utilise pour excipient des extraits végétaux enrichis en facteur hydratant naturel.Another object of the invention is to provide cosmetic preparations characterized by the fact that the mass of the solution for external use comprises from 9.5 to 10.5% of Aloes Vera extracts enriched in biostimulins, substantially 0, 25% of vitamin A, approximately 0.25% of vitamin E, and approximately 0.25% of vitamin F. An object of the invention is to provide cosmetic preparations characterized by the fact that the solution for external use uses as excipient plant extracts enriched with natural moisturizing factor.
Enfin, la présente invention a pour objet la mise en oeuvre des préparations cosmétiques caractérisées par le fait queFinally, the subject of the present invention is the use of cosmetic preparations characterized by the fact that
1'application de la solution à usage externe précède 1'application de la crème à usage externe qui comprend le facteur hydratant d'origine végétale.The application of the solution for external use precedes the application of the cream for external use which comprises the moisturizing factor of plant origin.
La description qui suit n'a qu'un but indicatif et non limitatif des préparations cosmétiques de l'invention.The description which follows has only an indicative and nonlimiting purpose of the cosmetic preparations of the invention.
La présente invention présente 1'avantage de considérer la peau telle qu'elle est, c'est-à-dire en organe complexe de notre organisme. Ainsi, il faut lui apporter une stimulation de l'extérieur mais surtout lui fournir de l'intérieur, l'ensemble des substances nécessaires à la biosynthèse d'élastine et de collagène, qui permettra à la peau de répondre favorablement à la stimulation extérieure.The present invention has the advantage of considering the skin as it is, that is to say as a complex organ of our organism. Thus, it must provide stimulation from the outside but above all provide it from the inside, all the substances necessary for the biosynthesis of elastin and collagen, which will allow the skin to respond favorably to external stimulation.
Ladite stimulation extérieure est le fait de facteurs externes tels que les biostimulines qui ont un rôle de stimulation générale sur l'ensemble des cellules epidermiques ainsi que sur les fibroblastes du derme qui synthétisent la matrice élastique formée de collagène et d'élastine.Said external stimulation is the result of external factors such as biostimulins which have a role of general stimulation on all the epidermal cells as well as on the fibroblasts of the dermis which synthesize the elastic matrix formed of collagen and elastin.
Cette biosynthèse des fibroblastes dépend de 1 'apport des acides aminés spécifiques qui manquent dans l'organisme.This fibroblast biosynthesis depends on the supply of specific amino acids which are lacking in the organism.
Ces substances, ainsi que les vitamines et les oligo-éléments indispensables à cette synthèse, peuvent être apportées par la voie sanguine d'où la nécessité d'utiliser un facteur interne sous forme d'un produit diététique spécifique pour la peau.These substances, as well as the vitamins and trace elements essential for this synthesis, can be supplied via the bloodstream, hence the need to use an internal factor in the form of a specific dietetic product for the skin.
De ce fait, les préparations cosmétiques régénérant la peau sont du type utilisant des produits à usage externe au corps humain mais également un produit à usage interne audit corps humain.Therefore, cosmetic preparations regenerating the skin are of the type using products for use external to the human body but also a product for internal use in said human body.
Les produits à usage externe stimulent 1'ensemble des cellules epidermiques ainsi que les fibroblastes se trouvant dans le derme et, de plus, permettent la revitalisation et 1'hydratation de 1'épiderme. Le produit à usage interne, pour sa part, véhicule plusieurs éléments dont les acides aminés et les oligo-éléments.The products for external use stimulate all the epidermal cells as well as the fibroblasts present in the dermis and, moreover, allow the revitalization and the hydration of the epidermis. The product for internal use, for its part, carries several elements including amino acids and trace elements.
Néanmoins, il est bon de préciser qu'un mélange comprenant une quantité aléatoire de vitamines, d'oligo-éléments et d'acides aminés n'est pas forcément des plus efficaces. Le produit à usage interne est formé d'acides aminés, de lécithine, de gelée royale lyophilisée, de vitamines et d'oligo¬ éléments.However, it should be noted that a mixture comprising a random amount of vitamins, trace elements and amino acids is not necessarily the most effective. The product for internal use consists of amino acids, lecithin, freeze-dried royal jelly, vitamins and trace elements.
Les produits à usage externe sont formés de deux crèmes et d'une solution. Les crèmes à usage externe sont formées d'huiles essentielles, de camomille romaine, de gelée royale lyophilisée et d'huile de germe de blé, de vitamines, de biostimulines et d'allantoïne, alors que la solution à usage externe est formée de vitamines, d'extraits d'Aloès Vera, et de biostimulines. La solution à usage externe utilise pour excipient des extraits végétaux enrichis en facteur hydratant naturel tel que des extraits de thé.The products for external use consist of two creams and a solution. Creams for external use are made of essential oils, Roman chamomile, freeze-dried royal jelly and wheat germ oil, vitamins, biostimulins and allantoin, while the solution for external use is formed of vitamins , extracts of Aloe Vera, and biostimulins. The solution for external use uses as excipient plant extracts enriched with natural moisturizing factor such as tea extracts.
En ce qui concerne le produit à usage interne, la masse de celui-ci comprend 33,9 % d'acides aminés.As regards the product for internal use, the mass thereof comprises 33.9% of amino acids.
Ces acides aminés sont, en proportion équivalente les uns par rapport aux autres, la lysine, la serine, l'histidine, la thréonine, la valine et/ou la leucine.These amino acids are, in equivalent proportion to one another, lysine, serine, histidine, threonine, valine and / or leucine.
La masse du produit à usage interne comprend également 24,2 % de lécithine, 22,6 % de gelée royale lyophilisée, 19,7 % de vitamines dont les vitamines C, B6 et B12 que l'on retrouve dans les proportions respectives suivantes : 5,1 %, 0,1 % et 0,02 %.The mass of the product for internal use also includes 24.2% lecithin, 22.6% lyophilized royal jelly, 19.7% vitamins including vitamins C, B6 and B12 which are found in the following respective proportions: 5.1%, 0.1% and 0.02%.
Les oligo-éléments sont nombreux et essentiels dans la biosynthèse de l'élastine et du collagène. Ils comprennent le sélénium, le zinc, le magnésium, le fer, le manganèse, le cuivre, le potassium, le cobalt, le germanium, le phosphate, le silicium, le chrome et/ou le vanadium.Trace elements are numerous and essential in the biosynthesis of elastin and collagen. They include selenium, zinc, magnesium, iron, manganese, copper, potassium, cobalt, germanium, phosphate, silicon, chromium and / or vanadium.
Lesdits oligo-éléments se retrouvent en proportion sensiblement équivalente les uns par rapport aux autres et forment 0,02 % de la masse du produit à usage interne.Said trace elements are found in substantially equivalent proportion to each other and form 0.02% of the mass of the product for internal use.
Les deux crèmes à usage externe ont une composition identique à un élément près.The two creams for external use have a composition identical to one element.
Ainsi, la masse de chaque crème à usage externe comprend 1Thus, the mass of each cream for external use includes 1
% d'huile essentielle de camomille romaine, 1,5 % de gelée royale, 2 % d'huile de germe de blé, 0,75 % de vitamines réparties en parts égales entre les vitamines A, E et F, 0,5 % de biostimulines et 0,5 d'allantoïne.% essential oil of Roman chamomile, 1.5% royal jelly, 2% wheat germ oil, 0.75% vitamins divided equally between vitamins A, E and F, 0.5% of biostimulins and 0.5 of allantoin.
L'une des deux crèmes à usage diurne comprend en plus un facteur hydratant d'origine végétale qui se retrouve dans une proportion de 2,5 % dans la masse de la crème à usage externe le contenant.One of the two daytime creams additionally includes a moisturizing factor of plant origin which is found in a proportion of 2.5% in the mass of the cream for external use containing it.
L'autre crème est à usage nocturne.The other cream is for night use.
Les crèmes à usage externe, qu'elles soients d'usage diurne ou nocturne, utilisent comme excipient une émulsion du type huile- dans-eau ce qui permet d'avoir des crèmes à usage externe qui ont la propriété d'avoir un potentiel hydrogène (Ph) égale à 6,8.Creams for external use, whether day or night use, use as an excipient an emulsion of the oil-in-water type which allows to have creams for external use which have the property of having a hydrogen potential. (Ph) equal to 6.8.
Le dernier produit de ces préparations cosmétiques est la solution à usage externe. La masse de celle-ci comprend 10 % d'extraits d'Aloès Vera, 0,5 % de biostimulines, mais également 0,75 % de vitamines réparties de la façon suivante : 0,25 % de vitamines A, 0,25 % de vitamine E et 0,25 % de vitamine F. Cette solution à usage externe a pour excipient des extraits végétaux enrichis en facteur hydratant naturel, tel que des extraits de thé.The last product of these cosmetic preparations is the solution for external use. Its mass includes 10% Aloe Vera extracts, 0.5% biostimulins, but also 0.75% vitamins distributed as follows: 0.25% Vitamins A, 0.25% of vitamin E and 0.25% of vitamin F. This solution for external use has for excipient vegetable extracts enriched in natural hydrating factor, such as extracts of tea.
De nombreuses études et des tests en milieux hospitaliers dermatologiques ont permis de révéler 1'inocuité des préparations cosmétiques de la présente invention et de démontrer 1'action régénérante revitalisante de celle-ci.Numerous studies and tests in dermatological hospital settings have made it possible to reveal the harmlessness of the cosmetic preparations of the present invention and to demonstrate the regenerating and revitalizing action thereof.
Le but des études a été d'apprécier les propriétés du traitement complet utilisant les deux crèmes, l'une pour le jour, l'autre pour la nuit, et la solution ainsi que le produit à usage interne, ce dernier étant présenté sous forme de gélules.The aim of the studies was to assess the properties of the complete treatment using the two creams, one for the day, the other for the night, and the solution as well as the product for internal use, the latter being presented in the form capsules.
L'appréciation des résultats a été possible par le fait' que les deux crèmes ont été appliquées sur la totalité du visage alors que la solution a été appliquée sur l'hémi-visage droit uniquement. Ceci a été fait sur dix sujets adultes volontaires pour une durée de 40 jours.The appreciation of the results was possible by the fact 'that the two creams were applied on the entire face while the solution was applied to the right half-face only. This was done on ten adult volunteers for 40 days.
Les résultats qui sont donnés ci-dessous représentent les mesures effectuées le 1er et le 40ème jour.The results which are given below represent the measurements carried out on the 1st and the 40th day.
L'administration des gélules a été quotidienne, trois fois par jour c'est-à-dire le matin, le midi et le soir.The administration of the capsules was daily, three times a day, that is to say in the morning, noon and evening.
L'application de la crème régénératrice de jour a été quotidienne, à huit heures du matin.The application of the regenerating day cream was daily, at eight in the morning.
L'application de la crème régénératrice et raffermissante de nuit a été quotidienne, jours aux environs de 22 heures. L'application de la solution a été quotidienne elle aussi, aux alentours de huit heures du matin.The application of the regenerating and firming cream at night was daily, days around 10 pm. The application of the solution was also daily, around eight o'clock in the morning.
L'application de la solution précède toujours l'application de la crème régénératrice et hydratante diurne.The application of the solution always precedes the application of the daytime regenerating and moisturizing cream.
Des empreintes de la peau ont été réalisées à l'aide d'un polymère synthétique spécialement utilisé pour cet usage.Skin prints were made using a synthetic polymer specially used for this purpose.
La lecture des empreintes a permis d'identifier deux zones : les plateaux et les sillons au niveau du front.Reading the footprints identified two areas: the plateaus and the furrows at the forehead.
Les résultats sont exprimés en % correspondant à la surface de la peau formant les plateaux ou les sillons par rapport aux 100 % de surface de peau étudiée en référence.The results are expressed in% corresponding to the surface of the skin forming the trays or the furrows compared to the 100 % of skin area studied by reference.
TABLEAU I : ETUDES DES PLATEAUXTABLE I: STUDIES OF THE TRAYS
Figure imgf000009_0001
On note, sur ce tableau, une évolution dans le sens de l'élargissement des plateaux.
Figure imgf000009_0001
We note, in this table, an evolution in the direction of the widening of the plates.
Néanmoins, entre le côté droit et le côté gauche une différence importante apparaît.Nevertheless, between the right side and the left side an important difference appears.
Entre le jour 1 noté JOUR 1H0 et le jour 40 noté JOUR 40H0, on note du côté droit une augmentation de 2,76 % de la surface des plateaux, alors que du côté gauche cette augmentation n'est que de 0,49 %.Between day 1 noted DAY 1H0 and day 40 noted DAY 40H0, there is an increase of 2.76% on the right side of the surface of the plates, while on the left side this increase is only 0.49%.
Il apparaît donc clairement que 1'hémi-visage droit sur lequel a été appliquée la solution, a évolué plus favorablement que 1'hémi-visage gauche.It therefore clearly appears that the right hemi-face on which the solution was applied has evolved more favorably than the left hemi-face.
TABLEAU II : ETUDE DES SILLONSTABLE II: STUDY OF FILLINGS
Figure imgf000009_0002
Figure imgf000009_0002
Ici encore, les effets sur la profondeur des sillons ne sont pas les mêmes entre le côté droit et le côté gauche.Here again, the effects on the depth of the furrows are not the same between the right side and the left side.
Les différences qui existent entre les deux côtés sont même plus importantes.The differences between the two sides are even more significant.
On note respectivement du côté droit une diminution de 2,96 % de la superficie des sillons, alors que du côté gauche cette diminution n'est que de 0,24 %. Là encore, la présence de solution contenant des biostimulines permet d'agir directement sur les cellules epidermiques .On the right side, there is a decrease of 2.96% in the area of the furrows, while on the left side, this decrease is only 0.24%. Again, the presence of a solution containing biostimulins makes it possible to act directly on the epidermal cells.
TABLEAU III : ETUDE DE L'EPAISSEUR DE L'EPIDERMETABLE III: STUDY OF THE THICKNESS OF THE EPIDERMIS
Figure imgf000010_0001
Figure imgf000010_0001
Dans ce dernier tableau, on comprend mieux la variation qui affecte 1'hémi-visage droit des sujets.In this last table, we understand better the variation which affects the right hemi-face of the subjects.
Ainsi, entre le 1er et le 40ème jour de traitement, les six sujets, dont les épaisseurs d'epiderme sont indiquées dans le tableau ci-dessus, montrent un épaississement substantiel dudit épiderme.Thus, between the 1st and the 40th day of treatment, the six subjects, whose epidermis thicknesses are indicated in the table above, show a substantial thickening of said epidermis.
Cette méthode consiste donc à traiter la peau de 1'extérieur et de 1'intérieur en même temps avec des substances actives complémentaires qui se retrouvent au niveau tissulaire de la peau, tout en participant ensemble au processus de revitalisation de ladite peau avec des effets prouvés sur 1'épaississement de 1'épiderme, sur son hydratation, sur l'élargissement des plateaux et sur la diminution des sillons.This method therefore consists in treating the skin from the outside and from the inside at the same time with active substances. which are found at the tissue level of the skin, while participating together in the process of revitalizing said skin with proven effects on the thickening of the epidermis, on its hydration, on the enlargement of the plateaus and on the reduction of furrows.
Les effets sur le derme sont 1'augmentation des fibres d'élastine et de collagène qui viennent s'ajouter aux fibres préexistantes, ce qui raffermit d'avantage la peau. The effects on the dermis are the increase in elastin and collagen fibers which are added to the pre-existing fibers, which firms the skin even more.

Claims

REVENDICATIONS
1. Préparations cosmétiques régénérant la peau du type utilisant des produits à usage externe au corps humain et un produit à usage interne audit corps humain, caractérisées par le fait que les produits à usage externe sont formés de deux crèmes et d'une solution, qui stimulent l'ensemble des cellules epidermiques et les fibroblastes du derme et qui protègent 1'épiderme et que le produit à usage interne est formé de gélules, qui véhiculent jusqu'aux cellules epidermiques et aux fibroblastes, entre autres, des acides aminés et des oligo-éléments.1. Cosmetic preparations regenerating the skin of the type using products for external use to the human body and a product for internal use in said human body, characterized in that the products for external use are formed by two creams and a solution, which stimulate all the epidermal cells and the fibroblasts of the dermis and which protect the epidermis and that the product for internal use is formed of capsules, which transport to the epidermal cells and to the fibroblasts, inter alia, amino acids and oligo -elements.
2. Préparations selon la revendication 1, caractérisées par le fait que la masse totale du produit à usage interne comprend :2. Preparations according to claim 1, characterized in that the total mass of the product for internal use comprises:
- de 33,4 à 34,4 % d'acides aminés,- from 33.4 to 34.4% of amino acids,
- de 23,7 à 24,7 % de lécithine,- from 23.7 to 24.7% of lecithin,
- de 22,1 à 23,1 % de gelée royale lyophilisée,- from 22.1 to 23.1% of lyophilized royal jelly,
- de 4,8 à 5,4 % de vitamine C, - sensiblement 0,1 % de vitamine B6,- from 4.8 to 5.4% of vitamin C, - substantially 0.1% of vitamin B6,
- sensiblement 0,02 % de vitamine B12, et- substantially 0.02% of vitamin B12, and
- sensiblement 0,02 % d'oligo-éléments.- substantially 0.02% of trace elements.
3. Préparations selon 1'une quelconque des revendications 1 ou 2, caractérisées par le fait que les acides aminés sont en proportions équivalentes la lysine, la serine, l'histidine, la thréonine, la valine et/ou la leucine.3. Preparations according to any one of claims 1 or 2, characterized in that the amino acids are in equivalent proportions lysine, serine, histidine, threonine, valine and / or leucine.
4. Préparations selon 1'une quelconque des revendications 1, 2 ou 3, caractérisées par le fait que les oligo-éléments sont formés par du sélénium, du zinc, du magnésium, du fer, du manganèse, du cuivre, du potassium, du cobalt, du germanium, du phosphate, du silicium, du chrome et/ou du vanadium.4. Preparations according to any one of claims 1, 2 or 3, characterized in that the trace elements are formed by selenium, zinc, magnesium, iron, manganese, copper, potassium, cobalt, germanium, phosphate, silicon, chromium and / or vanadium.
5. Préparations selon 1'une quelconque des revendications 1, 2, 3 ou 4, caractérisées par le fait que la masse de chaque crème à usage externe comprend :5. Preparations according to any one of claims 1, 2, 3 or 4, characterized in that the mass of each cream for external use comprises:
- sensiblement 1 % d'huile essentielle de camomille romaine,- substantially 1% essential oil of Roman chamomile,
- sensiblement 1,5 % de gelée royale,- approximately 1.5% royal jelly,
- sensiblement 2 % d'huile de germe de blé, - sensiblement 0,25 % de vitamine A,- substantially 2% wheat germ oil, - approximately 0.25% vitamin A,
- sensiblement 0,25 % de vitamine E,- approximately 0.25% vitamin E,
- sensiblement 0,25 % de vitamine F,- approximately 0.25% vitamin F,
- sensiblement 0,5 % de biostimulines, et - sensiblement 0,5 % d'allantoïne.- approximately 0.5% of biostimulins, and - approximately 0.5% of allantoin.
6. Préparations selon 1'une quelconque des revendications 1 ou 5, caractérisées par le fait que 1'une des deux crèmes à usage externe comprend un facteur hydratant d'origine végétale représentant sensiblement 2,5% de la masse de ladite crème à usage externe.6. Preparations according to any one of claims 1 or 5, characterized in that one of the two creams for external use comprises a moisturizing factor of plant origin representing substantially 2.5% of the mass of said cream for use external.
7. Préparations selon 1'une quelconque des revendications 1, 5 ou 6, caractérisées par le fait que les crèmes à usage externe utilisent pour excipient une émulsion du type huile-dans-eau. 8. Préparations selon l'une quelconque des revendications 1, 5, 6 ou 7, caractérisées par le fait que les crèmes à usage externe ont un potentiel hydrogène sensiblement de 6,7. Preparations according to any one of claims 1, 5 or 6, characterized in that the creams for external use use as an excipient an emulsion of the oil-in-water type. 8. Preparations according to any one of claims 1, 5, 6 or 7, characterized in that the creams for external use have a hydrogen potential of approximately 6,
8.8.
9. Préparations selon l'une quelconque des revendications 1, 2, 3, 4, 5, 6, 7 ou 8, caractérisées par le fait que la masse de la solution à usage externe comprend :9. Preparations according to any one of claims 1, 2, 3, 4, 5, 6, 7 or 8, characterized in that the mass of the solution for external use comprises:
- de 9,5 à 10,5 % d'extraits d'Aloes Vera,- from 9.5 to 10.5% of Aloes Vera extracts,
- sensiblement 0,5 % de biostimulines,- approximately 0.5% of biostimulins,
- sensiblement 0,25 % de vitamine A, - sensiblement 0,25 % de vitamine E, et- approximately 0.25% of vitamin A, - approximately 0.25% of vitamin E, and
- sensiblement 0,25 % de vitamine F.- approximately 0.25% vitamin F.
10. Préparations selon l'une quelconque des revendications 1 ou 9, caractérisées par le fait que la solution à usage externe utilise pour excipient des extraits végétaux enrichis en facteur hydratant naturel.10. Preparations according to any one of claims 1 or 9, characterized in that the solution for external use uses as excipient plant extracts enriched with natural moisturizing factor.
11. Préparations selon l'une quelconque des revendications 1, 2, 3, 4, 5, 6, 7, 8, 9 ou 10, caractérisées par le fait que 1'application de la solution à usage externe précède l'application de l'une des crèmes à usage externe. 11. Preparations according to any one of claims 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10, characterized in that the application of the solution for external use precedes the application of the 'one of the creams for external use.
PCT/FR1993/001077 1992-11-06 1993-10-29 Cosmetic preparations for revitalising the skin WO1994010974A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US08/211,807 US5520991A (en) 1992-11-06 1993-10-29 Cosmetic preparations for revitalizing the skin
EP93924663A EP0620726A1 (en) 1992-11-06 1993-10-29 Cosmetic preparations for revitalising the skin

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR92/13643 1992-11-06
FR9213643A FR2697750B1 (en) 1992-11-06 1992-11-06 Cosmetic preparations revitalizing the skin.
CA002083425A CA2083425C (en) 1992-11-06 1992-11-20 Cosmetic preparation for skin reconditioner

Publications (1)

Publication Number Publication Date
WO1994010974A1 true WO1994010974A1 (en) 1994-05-26

Family

ID=25675684

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR1993/001077 WO1994010974A1 (en) 1992-11-06 1993-10-29 Cosmetic preparations for revitalising the skin

Country Status (4)

Country Link
EP (1) EP0620726A1 (en)
CA (1) CA2083425C (en)
FR (1) FR2697750B1 (en)
WO (1) WO1994010974A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2138571A1 (en) * 1998-06-26 2000-01-01 Gimenez Gella Tatiana Cosmetic procedure for the treatment of the skin.

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022421A2 (en) * 1993-04-02 1994-10-13 Wogepharm Gmbh Use of water-soluble magnesium salts in preparations for external application, and new combination preparations containing such salts
US6149924A (en) * 1998-07-20 2000-11-21 Biomed Research & Technologies, Inc. Composition for enhancing lipid production, barrier function, hydrogen peroxide neutralization, and moisturization of the skin
MC200029A1 (en) * 2001-04-19 2001-11-28 Jose Eisenberg Application of three molecules
FR2886544B1 (en) * 2005-06-01 2008-07-11 Kiotis Soc Par Actions Simplif COSMETIC USE OF ESSENTIAL OILS

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1526996A (en) * 1967-02-14 1968-05-31 Beauty product
US4369180A (en) * 1981-09-10 1983-01-18 Randolph C. Karrh Cosmetic facial preparation containing aloe vera
FR2590169A1 (en) * 1985-11-20 1987-05-22 Secta Labo Cosmetologie Y Roch Cosmetic composition containing biostimulins
US4806525A (en) * 1987-06-18 1989-02-21 Mavi S.R.L. Formulation comprising gelatin and glycine for treating the dryness of skin
EP0330583A2 (en) * 1988-02-26 1989-08-30 L'oreal Method for enhancing the esthetic aspect of the skin with the aid of polyvitaminised mixtures, and cosmetic compositions for its application
FR2631824A1 (en) * 1988-05-31 1989-12-01 Fourreau Jacques Cosmetic skin care compositions of the face-pack and antiwrinkle cream type

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1526996A (en) * 1967-02-14 1968-05-31 Beauty product
US4369180A (en) * 1981-09-10 1983-01-18 Randolph C. Karrh Cosmetic facial preparation containing aloe vera
FR2590169A1 (en) * 1985-11-20 1987-05-22 Secta Labo Cosmetologie Y Roch Cosmetic composition containing biostimulins
US4806525A (en) * 1987-06-18 1989-02-21 Mavi S.R.L. Formulation comprising gelatin and glycine for treating the dryness of skin
EP0330583A2 (en) * 1988-02-26 1989-08-30 L'oreal Method for enhancing the esthetic aspect of the skin with the aid of polyvitaminised mixtures, and cosmetic compositions for its application
FR2631824A1 (en) * 1988-05-31 1989-12-01 Fourreau Jacques Cosmetic skin care compositions of the face-pack and antiwrinkle cream type

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2138571A1 (en) * 1998-06-26 2000-01-01 Gimenez Gella Tatiana Cosmetic procedure for the treatment of the skin.

Also Published As

Publication number Publication date
FR2697750A1 (en) 1994-05-13
CA2083425A1 (en) 1994-05-21
EP0620726A1 (en) 1994-10-26
FR2697750B1 (en) 1995-01-20
CA2083425C (en) 2000-09-19

Similar Documents

Publication Publication Date Title
KR100542606B1 (en) Skin and tissue care and/or treatment agent
FR2671487A1 (en) USE OF A GROWTH FACTOR IN A SLIMMING COMPOSITION.
FR2880802A1 (en) COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION CONTAINING EUGLENE EXTRACT
EP1837013B1 (en) Composition comprising hydroxyapatite and a calcium salt for reinforcing the barrier function of the skin and/or semi-mucus membranes.
FR2929511A1 (en) NEW ACTIVE PRINCIPLE STIMULATING THE PROLIFERATION AND / OR THE ACTIVITY OF FIBROBLASTS.
CH696135A5 (en) A set of four mutually compatible essential cosmetic compositions for the protection, nourishment, hydration and repair of the skin respectively and formulations comprising two or more of them
EP0655235B1 (en) Slimming composition
WO2005094776A1 (en) Cosmetic or dermatological compositions and applications thereof
CA2407294A1 (en) Plant extract of the olea europaea species as no-synthase inhibitor and uses
FR3112953A1 (en) Cosmetic use of the sacran
EP1768684B1 (en) Composition comprising a blue lotus extract for the treatment of facial uncontrolled muscular contractions
CA2083425C (en) Cosmetic preparation for skin reconditioner
EP2229145B1 (en) Use of a poppy petal extract for skin nutrition
FR3055546A1 (en) COSMETIC COMPOSITION COMPRISING A FRUIT EXTRACT FROM ARBUTUS UNEDO.
FR2801789A1 (en) Compositions comprise keratolin, a lipogenesis inhibitor and excipients for topical application, have a slimming effects on the face
FR2871382A1 (en) Topical cosmetic/dermatological composition, useful to fight against the signs of aging, comprises a complex extract of blue lotus and poppy
Caputo The spectrum of treatments for photodamage
WO2014001465A2 (en) Soothing topical composition containing paeonia and nymphaea extracts
FR3139466A1 (en) Use of a Sichuan pepper extract for skin treatment and a composition adapted to this use.
FR2871380A1 (en) Topical cosmetic and/or dermatological composition, used to fight against signs of cutaneous ageing and to prevent/treat uncontrolled facial muscular contractions, comprises blue lotus extract
FR2933302A1 (en) Cosmetic and dermatological compositions, useful to activate cells of dermis via action on adipocytes of hypodermis, comprise mixture of vegetable oil or its derivative, ceramide derivative and plant extracts/purified molecules
WO2003077934A1 (en) Use of a biotechnological honey substitute in a cosmetic or dermatological composition
FR2871381A1 (en) Topical cosmetic/dermatological composition, useful e.g. to fight against signs of cutaneous ageing, comprises an marsh mallow extract (Althea officinalis)
WO2012140352A2 (en) Gleditsia composition for treating excess fat
MXPA99001828A (en) Lip treatment containing live yeast cell derivative

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 08211807

Country of ref document: US

AK Designated states

Kind code of ref document: A1

Designated state(s): NO RU US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 1993924663

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWP Wipo information: published in national office

Ref document number: 1993924663

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: 1993924663

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1993924663

Country of ref document: EP